Significant survival predictors include tumor stage, lymph node stage, carcinoembryonic antigen (CEA), chemotherapy treatment, radiomics signature, and DL signature (HR = 1.336/1.768, p < 0.005). The gene discussed is CEACAM5; the disease is neoplasm.